Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Acute Pancreatitis Therapy
Research from Medical University of Graz, Institute of Experimental and Clinical Pharmacology has provided new data on acute pancreatitis therapy
March 23rd, 2008
Current study results from the report, 'Anti-inflammatory actions of perfluorooctanoic acid and peroxisome proliferator-activated receptors (PPAR) alpha and gamma in experimental acute pancreatitis,' have been published. According to recent research published in the journal International Immunopharmacology, "Perfluorooctanoic acid (PFOA) and agonists of peroxisome proliferator-activated receptors (PPAR) alpha and gamma were investigated for potential anti-inflammatory effects in cerulein-induced acute pancreatitis in rats. PFOA significantly reduced both leukocyte accumulation and prostanoid synthesis." "The PPAR-alpha agonist clofibrate had no effect on...
Source: Pharma Investments, Ventures & Law Weekly (2008-03-23)
|
